282
Views
134
CrossRef citations to date
0
Altmetric
Original Article

Pharmacokinetics and Side Effects of Perfluorocarbon-Based Blood Substitutes

Pages 1043-1054 | Published online: 11 Jul 2009

References

  • Ricss J. G. Overview of progress in the fluorocarbon approach to in vivo oxygen delivery. Blood Substitutes and Oxygen Carriers, T. MS. Chang. Marcel Dekker Inc., New York 1993; 24
  • Tatlow J. C. Aspects of organofluorine chemicals. Organofluorine chemicals and their industrial applications, R. E. Banks. Ellis Horwood Ltd., Chichester 1979; 19
  • Riess J. G. Blood substitutes: Where do we stand with the fluorocarbon approach. Curr Surg 1988; 45: 365–370
  • Kitazawa M., Ohnishi Y. Long term experiment of perfluorochemicals using rabbits. Virchow Arch (Pathol Anal) 1982; 398: 1–10
  • Nanney L., Fink L. M., Virmani R. Perfluorochemicals: morphologic changes in infused liver, spleen, lung, and kidney of rabbits. Arch Pathol Lab Med 1984; 108: 631–637
  • Ohnishi Y., Kitazawa M. Application of perfluorochemicals in human beings. A morphological report of a human autopsy case with some experimental studies using rabbit. Acta Pathol Jpn 1980; 30: 489–504
  • Tsuda Y., Nakura K., Yamanouchi K., Yokoyama K., Watanabe M., Ohyanagi H., Saitoh Y. Study of the excretion mechanism of a perfluorochemical emulsion. Artificial Organs 1989; 13: 197–203
  • Clark L. C., Hoffmann R. E., Spokane R. B., Winston P. E. Physiological evaluation of fluorocarbon emulsions with notes on F-decalin and pulmonary inflation in the rabbit. Mat Res Soc Symp Proc 1989; 110: 129–134
  • Clark L. C., Hoffmann R. E., Davis S. L. Response of the rabbit lung as a criterion of safety for fluorocarbon breathing and blood substitutes. Biomat Art Cell Immob Biotech 1992; 20: 1085–1099
  • Vercellotti G. M., Hammerschmidt D. E., Craddock P. R., Jacob H. S. Activation of plasma complement by perfluorocarbon artificial blood: probable mechanism of adverse pulmonary reactions in treated patients and rational for corticosteroid prophylaxis. Blood 1982; 59: 1299–1304
  • Police A. M., Waxman K., Toninaga G. Pulmonary complications after Fluosol administration to patients with life threating blood loss. Crit Care Med 1985; 13: 96–98
  • Waxman K., Tremper K. K., Cullen B. F., Mason G. R. Perfluorocarbon infusion in bleeding patients refusing blood transfusions. Arch Surg 1984; 119: 721–724
  • Riess J. G., Le Blanc M. Solubility and transport phenomena in PFCs relevant to blood substitution and other biomedical applications. Pure and Appl Cem 1982; 54: 2383–2406
  • Riess J. G. Reassessment of criteria for the selection of perfluorochemicals for second generation blood substitutes: Analysis of structure/property relationships. Artif Org 1984; 8: 44–56
  • Flaim S. F., Hazard D. R., Hogan J., Peters R. M. Characterization and mechanism of side-effects of Imagent® BP (highly concentrated fluorocarbon emulsion) in swine. Invest Radiol 1991; 26: S122–S124

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.